About 1,670,395 results (4,073 milliseconds)

US6395294B1 - Method of visualization of the vitreous during ...

https://patents.google.com/patent/US6395294B1/en
... injection), or systemic. Because prolonged systemic corticosteroid use has undesired side effects, local administration is preferred whenever possible. The ...

WO2020102474A1 - Stable glucocorticoid formulation - Google ...

https://patents.google.com/patent/WO2020102474A1/en
... adverse side effects associated with use of such antioxidant preservatives. ... EXAMPLE METHOD [0213] Assay and Related Substances (UPLC) for Dexamethasone ...

US10537585B2 - Compositions comprising dexamethasone ...

https://patents.google.com/patent/US10537585B2/en
As the recommended dose of dexamethasone for treatment of multiple myeloma is ... adverse side effect known or suspected of being caused by the drug.

WO2016118649A1 - Pharmaceutical formulation - Google Patents

https://patents.google.com/patent/WO2016118649A1/en
The dose per injection of dexamethasone is in the range of 3 to 20 mg/dose in 1 to 10 ml of a sterile solution such as water for injection or saline. [0060] Yet ...

RU2471479C1 - Tableted pharmaceutical composition containing ...

https://patents.google.com/patent/RU2471479C1/en
... side effects caused by prolonged treatment. 2 cl, 4 ex. ... Oral injection of dexamethasone injections cannot guarantee a safe and effective treatment.

EP2991706A2 - Apparatus and methods for ocular injection ...

https://patents.google.com/patent/EP2991706A2/en
... decadron Drugs 0.000 description ... IVT administration can have side effects such as increased intraocular pressure or faster onset of cataract formation.

WO2023092046A1 - Process and therapeutic composition for ...

https://patents.google.com/patent/WO2023092046A1/en
[0004] Injection site reactions (ISRs) can be an issue in the development ... treatment of CNS disorders and reducing side effects such as ISR. SUMMARY.

EP3250251A1 - Joint fat pad formulations, and methods of use ...

https://patents.google.com/patent/EP3250251A1/en
... side effects. Several compounds and delivery methods have been investigated ... Dexamethasone sodium phosphate injection (Decadron®, Pfizer Injectables ...

US20200188368A1 - Novel triple combination formulations for ...

https://patents.google.com/patent/US20200188368A1/en
... side effects. Dexamethasone and other glucocorticoids or corticosteroids are ... Fosaprepitant lyophilizate and liquid injection formulation with Palonosetron and ...

ES2877371T3 - Injectable pharmaceutical composition comprising ...

https://patents.google.com/patent/ES2877371T3/en
... effects, such as arachnoiditis caused by an epidural injection. ... The present formulation does not include polyethylene glycol due to possible side effects.

US4177267A - Enhancing tissue penetration of physiologically ...

https://patents.google.com/patent/US4177267A/en
Also, undesirable side effects may result which prevent effective oral administration. (2) In every case where injection must be resorted to, there is a risk of ...

WO1995031194A1 - Compositions for treatment of chronic ...

https://patents.google.com/patent/WO1995031194A1/en
Significant adverse side effects accompany many of these treatments, which limit their use. ... (h' ' ' ' ) dexamethasone (Decadron phosphate injection,' Merck & ...

US20050090553A1 - Compositions and method for treatment of ...

https://patents.google.com/patent/US20050090553A1/en
Significant adverse side effects accompany many of these treatments, which limit their use. ... dosage levels, thus minimizing adverse side effects. Within the ...

EP2515929A1 - Methods and use related to humanin and humanin ...

https://patents.google.com/patent/EP2515929A1/en
completely prevents the negative effects of dexamethasone or chemotherapy, wihout interfering with the primary effects of the drugs is of considerable clinical ...

BR112021009365A2 - stable glucocorticoid formulation - Google ...

https://patents.google.com/patent/BR112021009365A2/en
[009] Achieving stability of a drug formulation without the potential toxicological side effects ... Dexamethasone Phosphate Injection. Details of a UPLC ...

US20140249118A1 - Treatment of oral lichen planus with a ...

https://patents.google.com/patent/US20140249118A1/en
... use without systemic side effects [5]. Triamcinolone acetonide 0.1% (mid ... 2013 Effect of submucosal injection of dexamethasone on postoperative discomfort ...

US8486926B2 - Steroid tetrol solid state forms - Google Patents

https://patents.google.com/patent/US8486926B2/en
This allows the continued use, or a modified dosage of the corticosteroid, e.g., an increased dosage, without an intensification of the side effects or ...

US9233068B2 - Controlled release antimicrobial compositions and ...

https://patents.google.com/patent/US9233068B2/en
... treatment of the otic disorders contemplated herein with minimal side effects in the targeted regions or areas. Intratympanic injection of compositions or ...

WO2009108626A2 - Enhanced delivery of a therapeutic to ocular ...

https://patents.google.com/patent/WO2009108626A2/en
Long- term dexamethasone treatment, however, can have negative effects such as elevated intraocular pressure. The efficacy of a single iontophoretically ...

US9757452B2 - Methods of treatment of keloid using an anti-VEGF ...

https://patents.google.com/patent/US9757452B2/en
Suitable anti-inflammatory steroids for injection into the eye and suitable for use in the methods described herein include, e.g., triamcinolone acetonide ( ...